Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion type Assertion NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_head.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion description "[Heterozygous carriers of the MAL/TIRAP variant S180L were more prevalent in the asymptomatic group (24 [32%] of 76 subjects) than in the CCC group (21 [12%] of 169) (chi2=12.6; P=.0004 [adjusted P (Pc)=.0084]; odds ratio [OR], 0.31 [95% confidence interval {CI}, 0.16-0.60]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_provenance.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion evidence source_evidence_literature NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_provenance.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion SIO_000772 19456234 NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_provenance.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion wasDerivedFrom befree-20140225 NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_provenance.
- NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_assertion wasGeneratedBy ECO_0000203 NP458212.RAyEQEfXpU01vGiXH7uSp4KqcVrV-5pqHgy9pTiW04sqc130_provenance.